Cell Mol Immunol . 2022 Sep 1. doi: 10.1038/s41423-022-00917-7. Online ahead of print. USP3 deubiquitinates and stabilizes the adapter protein ASC to regulate inflammasome activation. (IF:22.096).
Cell Rep . 2022 Aug 16;40(7):111195. doi: 10.1016/j.celrep.2022.111195. Nondegradable ubiquitinated ATG9A organizes Golgi integrity and dynamics upon stresses.
Research (Wash D C) . 2022 Jul 19;2022:9826426. doi: 10.34133/2022/9826426. eCollection 2022. Programming of Regulatory T Cells In Situ for Nerve Regeneration and Long-Term Patency of Vascular Grafts. (IF:11.036).
Int J Biol Sci. 2022; 18(11): 4329–4340. Published online 2022 Jul 4. doi: 10.7150/ijbs.71581. PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis. (IF:10.75).
Environ Pollut . 2022 Sep 1;308:119607. doi: 10.1016/j.envpol.2022.119607. Epub 2022 Jun 16. Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5. (IF:9.988).
iScience . 2022 Apr 13;25(5):104249. doi: 10.1016/j.isci.2022.104249. eCollection 2022 May 20. L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy. (IF:6.107).
Cell Cycle. 2022 Apr 9;1-21. doi: 10.1080/15384101.2022.2057633. Online ahead of print. Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184
Acta Pharmacol Sin. 2022 Apr 6. doi: 10.1038/s41401-022-00893-8. Online ahead of print. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9 (IF:6.150).
J Med Genet. 2022 Mar 31;jmedgenet-2021-108259. doi: 10.1136/jmedgenet-2021-108259. Online ahead of print. Novel truncating variants in CTNNB1 cause familial exudative vitreoretinopathy (IF:6.318).
Environ Toxicol.2022 Mar;37(3):539-548.doi: 10.1002/tox.23419. Epub 2021 Nov 24. MicroRNA-577 aggravates bone loss and bone remodeling by targeting thyroid stimulating hormone receptor in hyperthyroid-associated osteoporosis
